Over the past 12 months, 2 insiders at PMV Pharmaceuticals, Inc. filed 2 open-market SEC Form 4 transactions on PMVP: 0 purchases worth $0 and 2 sales worth $2.4M. Insiders have been net sellers over this period. The most recent filing was on Oct 23, 25.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 25 | Orbimed Capital Gp V LlcTenPercentOwner | SELL | 1.00M | $1.52 | $1.5M |
| Sep 10, 25 | Orbimed Advisors LlcTenPercentOwner | SELL | 500.0K | $1.80 | $900K |
| Jul 1, 25 | Michael CarulliChief Financial Officer | SELL | 28.2K | $1.06 | $30K |
| Jul 1, 25 | Deepika JalotaChief Development Officer | SELL | 33.1K | $1.06 | $35K |
| Jul 1, 25 | David Henry MackPresident and CEO | SELL | 58.4K | $1.06 | $62K |
| Jul 1, 25 | Robert TicktinGeneral Counsel & COO | SELL | 23.2K | $1.06 | $25K |
| Sep 11, 24 | Michael CarulliChief Financial Officer | SELL | 2.9K | $1.50 | $4K |
| Sep 11, 24 | Deepika JalotaChief Development Officer | SELL | 7.2K | $1.50 | $11K |
| Nov 22, 23 | Orbimed Genesis Gp LlcTenPercentOwner | SELL | 87.8K | $2.23 | $196K |
| Sep 15, 23 | Leila AllandChief Medical Officer | SELL | 6.3K | $6.62 | $42K |
| Sep 15, 23 | Deepika JalotaChief Development Officer | SELL | 4.1K | $6.62 | $27K |
| May 26, 22 | Orbimed Capital Gp V LlcTenPercentOwner | SELL | 26.3K | $15.93 | $418K |
| Mar 31, 22 | Orbimed Genesis Gp LlcTenPercentOwner | SELL | 34.5K | $21.17 | $730K |
| Mar 30, 22 | Orbimed Genesis Gp LlcTenPercentOwner | SELL | 75.0K | $22.39 | $1.7M |
| Mar 29, 22 | Orbimed Genesis Gp LlcTenPercentOwner | SELL | 365.0K | $21.52 | $7.9M |
| Oct 6, 21 | Thilo SchroederDirector | SELL | 800 | $30.15 | $24K |
| Oct 4, 21 | Thilo SchroederDirector | SELL | 100 | $30.08 | $3K |
| Oct 1, 21 | Thilo SchroederDirector | SELL | 11.5K | $30.10 | $347K |
| Sep 30, 21 | Thilo SchroederDirector | SELL | 3.0K | $30.03 | $89K |
| Sep 29, 21 | Thilo SchroederDirector | SELL | 5.7K | $30.04 | $171K |
| Sep 27, 21 | Thilo SchroederDirector | SELL | 1.8K | $30.11 | $53K |
| Sep 22, 21 | Arnold J LevineDirector | SELL | 3.5K | $30.00 | $105K |
| Sep 22, 21 | Thilo SchroederDirector | SELL | 100 | $30.00 | $3K |
| Sep 17, 21 | Thilo SchroederDirector | SELL | 711 | $30.03 | $21K |
| Sep 13, 21 | Thilo SchroederDirector | SELL | 13.3K | $30.20 | $401K |
| Sep 10, 21 | Thilo SchroederDirector | SELL | 38.1K | $31.03 | $1.2M |
| Sep 9, 21 | Leila AllandChief Medical Officer | SELL | 100 | $30.25 | $3K |
| Sep 9, 21 | Thilo SchroederDirector | SELL | 14.3K | $30.31 | $434K |
| Sep 7, 21 | Leila AllandChief Medical Officer | SELL | 3.9K | $30.25 | $118K |
| Sep 2, 21 | Thilo SchroederDirector | SELL | 5.4K | $30.15 | $163K |
| Sep 1, 21 | Thilo SchroederDirector | SELL | 22.0K | $30.38 | $668K |
| Aug 31, 21 | Thilo SchroederDirector | SELL | 19.5K | $30.12 | $588K |
| Aug 30, 21 | Thilo SchroederDirector | SELL | 13.2K | $30.05 | $398K |
| Aug 27, 21 | Thilo SchroederDirector | SELL | 23.4K | $31.06 | $714K |
| Aug 26, 21 | Thilo SchroederDirector | SELL | 15.1K | $31.13 | $458K |
| Aug 25, 21 | Thilo SchroederDirector | SELL | 13.5K | $31.01 | $419K |
| Aug 24, 21 | Thilo SchroederDirector | SELL | 14.5K | $31.08 | $450K |
| Aug 23, 21 | Arnold J LevineDirector | SELL | 3.5K | $29.50 | $103K |
| Aug 23, 21 | Thilo SchroederDirector | SELL | 23.1K | $31.06 | $709K |
| Aug 19, 21 | Thilo SchroederDirector | SELL | 3.8K | $30.97 | $118K |
| Aug 18, 21 | Thilo SchroederDirector | SELL | 13.2K | $34.32 | $447K |
| Aug 17, 21 | Deepika JalotaSVP, Regulatory Affairs and QA | SELL | 2.9K | $33.78 | $98K |
| Aug 17, 21 | Thilo SchroederDirector | SELL | 15.7K | $33.93 | $534K |
| Aug 16, 21 | Thilo SchroederDirector | SELL | 19.6K | $34.54 | $662K |
| Aug 13, 21 | Thilo SchroederDirector | SELL | 25.8K | $34.66 | $882K |
| Aug 12, 21 | Thilo SchroederDirector | SELL | 11.6K | $34.83 | $397K |
| Aug 11, 21 | Thilo SchroederDirector | SELL | 34.4K | $34.04 | $1.2M |
| Aug 10, 21 | Thilo SchroederDirector | SELL | 17.9K | $35.54 | $622K |
| Aug 9, 21 | Leila AllandChief Medical Officer | SELL | 2.2K | $36.69 | $77K |
| Aug 9, 21 | Thilo SchroederDirector | SELL | 13.3K | $36.64 | $466K |
Over the past 12 months, insiders at PMV Pharmaceuticals, Inc. filed 0 open-market purchases worth $0 and 2 sales worth $2.4M on PMVP, which makes them net sellers over the period. The most recent Form 4 was filed on Oct 23, 25.
2 different insiders at PMV Pharmaceuticals, Inc. filed open-market SEC Form 4 transactions on PMVP over the last 12 months.
InsiderTape plots every PMVP insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every PMV Pharmaceuticals, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →